Prostate-Specific Antigen (PSA) Testing Market Report

Global Prostate-Specific Antigen (PSA) Testing Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 07, 2021
  • PAGES：204
  • REPORT CODE：GMM642882
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Prostate-Specific Antigen (PSA) Testing is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Prostate-Specific Antigen (PSA) Testing market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Prostate-Specific Antigen (PSA) Testing industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Prostate-Specific Antigen (PSA) Testing Market Segmentations:

    By Players:

    • Sanofi-Aventis SA

    • Fujirebio

    • Tosoh

    • Bayer AG

    • Bristol-Myers Squibb Company

    • Boston Scientific Corporation

    • Roche

    • Merck＆Co

    • Siemens Healthcare

    • Beckman Coulter

    • Abbott

    • Mediwatch

    • PerkinElmer

    • GE Healthcare

    • DiaSorin

    • Ortho Clinical

    • Medtronic

    • Endocare

    • BodiTech

    By Types:

    • Chemiluminescence Immunoassay Method

    • Enzyme Linked Immunosorbent Assay Method

    By End-User:

    • Screening

    • Post-treatment Monitoring

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate-Specific Antigen (PSA) Testing Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Chemiluminescence Immunoassay Method from 2014 to 2026

      • 1.3.2 Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Enzyme Linked Immunosorbent Assay Method from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Screening from 2014 to 2026

      • 1.4.2 Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Post-treatment Monitoring from 2014 to 2026

      • 1.4.3 Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prostate-Specific Antigen (PSA) Testing Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prostate-Specific Antigen (PSA) Testing by Major Types

      • 3.4.1 Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Chemiluminescence Immunoassay Method

      • 3.4.2 Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Enzyme Linked Immunosorbent Assay Method

    4 Segmentation of Prostate-Specific Antigen (PSA) Testing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prostate-Specific Antigen (PSA) Testing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prostate-Specific Antigen (PSA) Testing in Screening

      • 4.4.2 Market Size and Growth Rate of Prostate-Specific Antigen (PSA) Testing in Post-treatment Monitoring

      • 4.4.3 Market Size and Growth Rate of Prostate-Specific Antigen (PSA) Testing in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Prostate-Specific Antigen (PSA) Testing Production Analysis by Major Regions

    • 5.2 Global Prostate-Specific Antigen (PSA) Testing Consumption Analysis by Major Regions

    • 5.3 Global Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis

    6 Product Commodity of Prostate-Specific Antigen (PSA) Testing Market in Major Countries

    • 6.1 Top 5 Export Countries in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Prostate-Specific Antigen (PSA) Testing Landscape Analysis

    • 7.1 North America Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major Types

    • 7.2 North America Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major End-Users

    • 7.3 North America Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major Countries

      • 7.3.1 United States Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 7.3.2 Canada Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 7.3.3 Mexico Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

    8 Europe Prostate-Specific Antigen (PSA) Testing Landscape Analysis

    • 8.1 Europe Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major Types

    • 8.2 Europe Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major End-Users

    • 8.3 Europe Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major Countries

      • 8.3.1 Germany Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.2 UK Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.3 France Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.4 Italy Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.6 Spain Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.7 Belgium Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.8 Poland Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.9 Russia Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 8.3.10 Turkey Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

    9 Asia Pacific Prostate-Specific Antigen (PSA) Testing Landscape Analysis

    • 9.1 Asia Pacific Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major Types

    • 9.2 Asia Pacific Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major Countries

      • 9.3.1 China Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 9.3.2 Japan Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 9.3.4 India Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 9.3.6 South Korea Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 10.3.2 Brazil Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 10.3.3 Nigeria Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

      • 10.3.4 South Africa Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate 

      • 10.3.5 Argentina Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Sanofi-Aventis SA

      • 11.1.1 Sanofi-Aventis SA Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Fujirebio

      • 11.2.1 Fujirebio Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Tosoh

      • 11.3.1 Tosoh Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Bayer AG

      • 11.4.1 Bayer AG Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Bristol-Myers Squibb Company

      • 11.5.1 Bristol-Myers Squibb Company Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Boston Scientific Corporation

      • 11.6.1 Boston Scientific Corporation Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Roche

      • 11.7.1 Roche Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Merck＆Co

      • 11.8.1 Merck＆Co Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Siemens Healthcare

      • 11.9.1 Siemens Healthcare Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Beckman Coulter

      • 11.10.1 Beckman Coulter Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Abbott

      • 11.11.1 Abbott Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Mediwatch

      • 11.12.1 Mediwatch Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 PerkinElmer

      • 11.13.1 PerkinElmer Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 GE Healthcare

      • 11.14.1 GE Healthcare Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 DiaSorin

      • 11.15.1 DiaSorin Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Ortho Clinical

      • 11.16.1 Ortho Clinical Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Medtronic

      • 11.17.1 Medtronic Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Endocare

      • 11.18.1 Endocare Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 BodiTech

      • 11.19.1 BodiTech Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 94 Figures and 189 Tables)

    • Figure Product Picture

    • Figure Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Chemiluminescence Immunoassay Method from 2014 to 2026

    • Figure Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Enzyme Linked Immunosorbent Assay Method from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Screening from 2014 to 2026

    • Figure Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Post-treatment Monitoring from 2014 to 2026

    • Figure Global Prostate-Specific Antigen (PSA) Testing Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Prostate-Specific Antigen (PSA) Testing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prostate-Specific Antigen (PSA) Testing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prostate-Specific Antigen (PSA) Testing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prostate-Specific Antigen (PSA) Testing by Different Types from 2014 to 2026

    • Table Consumption Share of Prostate-Specific Antigen (PSA) Testing by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Chemiluminescence Immunoassay Method

    • Figure Market Size and Growth Rate of Enzyme Linked Immunosorbent Assay Method

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prostate-Specific Antigen (PSA) Testing by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prostate-Specific Antigen (PSA) Testing by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Screening

    • Figure Market Size and Growth Rate of Post-treatment Monitoring

    • Figure Market Size and Growth Rate of Other

    • Table Global Prostate-Specific Antigen (PSA) Testing Production by Major Regions

    • Table Global Prostate-Specific Antigen (PSA) Testing Production Share by Major Regions

    • Figure Global Prostate-Specific Antigen (PSA) Testing Production Share by Major Regions in 2014

    • Figure Global Prostate-Specific Antigen (PSA) Testing Production Share by Major Regions in 2018

    • Figure Global Prostate-Specific Antigen (PSA) Testing Production Share by Major Regions in 2026

    • Table Global Prostate-Specific Antigen (PSA) Testing Consumption by Major Regions

    • Table Global Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Regions

    • Figure Global Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Regions in 2014

    • Figure Global Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Regions in 2018

    • Figure Global Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Regions in 2026

    • Table North America Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis

    • Table Europe Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Prostate-Specific Antigen (PSA) Testing market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Prostate-Specific Antigen (PSA) Testing Consumption by Types from 2014 to 2026

    • Table North America Prostate-Specific Antigen (PSA) Testing Consumption Share by Types from 2014 to 2026

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2014

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2018

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2026

    • Table North America Prostate-Specific Antigen (PSA) Testing Consumption by End-Users from 2014 to 2026

    • Table North America Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users from 2014 to 2026

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2014

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2018

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2026

    • Table North America Prostate-Specific Antigen (PSA) Testing Consumption by Major Countries from 2014 to 2026

    • Table North America Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2014

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2018

    • Figure North America Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2026

    • Figure United States Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Prostate-Specific Antigen (PSA) Testing Consumption by Types from 2014 to 2026

    • Table Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by Types from 2014 to 2026

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2014

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2018

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2026

    • Table Europe Prostate-Specific Antigen (PSA) Testing Consumption by End-Users from 2014 to 2026

    • Table Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2014

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2018

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2026

    • Table Europe Prostate-Specific Antigen (PSA) Testing Consumption by Major Countries from 2014 to 2026

    • Table Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2014

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2018

    • Figure Europe Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2026

    • Figure Germany Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure France Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption by Types from 2014 to 2026

    • Table Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2014

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2018

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2026

    • Table Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2014

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2018

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2026

    • Table Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2026

    • Figure China Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandProstate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure India Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Prostate-Specific Antigen (PSA) Testing Consumption Share by Major Countries in 2026

    • Figure GCC Countries Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Prostate-Specific Antigen (PSA) Testing Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Sanofi-Aventis SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis SA

    • Figure Sales and Growth Rate Analysis of Sanofi-Aventis SA

    • Figure Revenue and Market Share Analysis of Sanofi-Aventis SA

    • Table Product and Service Introduction of Sanofi-Aventis SA

    • Table Company Profile and Development Status of Fujirebio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujirebio

    • Figure Sales and Growth Rate Analysis of Fujirebio

    • Figure Revenue and Market Share Analysis of Fujirebio

    • Table Product and Service Introduction of Fujirebio

    • Table Company Profile and Development Status of Tosoh

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tosoh

    • Figure Sales and Growth Rate Analysis of Tosoh

    • Figure Revenue and Market Share Analysis of Tosoh

    • Table Product and Service Introduction of Tosoh

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company

    • Table Company Profile and Development Status of Boston Scientific Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boston Scientific Corporation

    • Figure Sales and Growth Rate Analysis of Boston Scientific Corporation

    • Figure Revenue and Market Share Analysis of Boston Scientific Corporation

    • Table Product and Service Introduction of Boston Scientific Corporation

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Merck＆Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck＆Co

    • Figure Sales and Growth Rate Analysis of Merck＆Co

    • Figure Revenue and Market Share Analysis of Merck＆Co

    • Table Product and Service Introduction of Merck＆Co

    • Table Company Profile and Development Status of Siemens Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare

    • Figure Revenue and Market Share Analysis of Siemens Healthcare

    • Table Product and Service Introduction of Siemens Healthcare

    • Table Company Profile and Development Status of Beckman Coulter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beckman Coulter

    • Figure Sales and Growth Rate Analysis of Beckman Coulter

    • Figure Revenue and Market Share Analysis of Beckman Coulter

    • Table Product and Service Introduction of Beckman Coulter

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Mediwatch

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mediwatch

    • Figure Sales and Growth Rate Analysis of Mediwatch

    • Figure Revenue and Market Share Analysis of Mediwatch

    • Table Product and Service Introduction of Mediwatch

    • Table Company Profile and Development Status of PerkinElmer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PerkinElmer

    • Figure Sales and Growth Rate Analysis of PerkinElmer

    • Figure Revenue and Market Share Analysis of PerkinElmer

    • Table Product and Service Introduction of PerkinElmer

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of DiaSorin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DiaSorin

    • Figure Sales and Growth Rate Analysis of DiaSorin

    • Figure Revenue and Market Share Analysis of DiaSorin

    • Table Product and Service Introduction of DiaSorin

    • Table Company Profile and Development Status of Ortho Clinical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ortho Clinical

    • Figure Sales and Growth Rate Analysis of Ortho Clinical

    • Figure Revenue and Market Share Analysis of Ortho Clinical

    • Table Product and Service Introduction of Ortho Clinical

    • Table Company Profile and Development Status of Medtronic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic

    • Figure Sales and Growth Rate Analysis of Medtronic

    • Figure Revenue and Market Share Analysis of Medtronic

    • Table Product and Service Introduction of Medtronic

    • Table Company Profile and Development Status of Endocare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endocare

    • Figure Sales and Growth Rate Analysis of Endocare

    • Figure Revenue and Market Share Analysis of Endocare

    • Table Product and Service Introduction of Endocare

    • Table Company Profile and Development Status of BodiTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BodiTech

    • Figure Sales and Growth Rate Analysis of BodiTech

    • Figure Revenue and Market Share Analysis of BodiTech

    • Table Product and Service Introduction of BodiTech


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US